Platelet parameters as indicators of arteriovenous fistula thrombosis in hemodialysis patients
DOI:
https://doi.org/10.2478/AMB-2026-0069Keywords:
platelet parameters, hemodialysis, arteriovenous (AV) fistula, thrombosisAbstract
Abstract. Background: The total number of platelets (PLT), plateletcrit (PCT), mean platelet volume (MPV), and platelet distribution width (PDW) are utilized as markers of platelet activation in assessing thrombotic vascular events. Given the critical importance of maintaining adequate vascular access, i.e., arteriovenous (AV) fistula, for the survival of hemodialysis (HD) patients, the question arises: Is it possible to detect changes in platelet parameters that indicate a connection to occurrences of thrombotic complications with AV fistula? Materials and methods: The study involved 100 patients diagnosed with end-stage renal disease, admitted to the Clinic of Hemodialysis at the University Clinical Center Sarajevo (UCCS). All patients underwent standard bicarbonate HD three times a week, utilizing a native AV fistula for access. The study group was divided into two subgroups: patients without confirmed AV fistula thrombosis (AVF-nonT; n = 66) and patients with confirmed AV fistula thrombosis (AVF-T; n = 34). Anamnestic data and platelet parameter values were collected during the surveyed period. Results: The average value of the PLT was significantly lower (p = 0.001), while the average value of the MPV was significantly higher (p = 0.0001) in patients of the AVF-T group in relation to the patients in the AVF-nonT group. In differentiating patients of the AVF-T group and patients of the AVF-nonT group, PLT in peripheral blood had a moderately good diagnostic accuracy (AUC = 0.704; p = 0.001), and MPV had an excellent diagnostic accuracy (AUC = 0.991; p < 0.001). Conclusion: PLT and MPV can be used as effective biomarkers of AV fistula thrombosis in patients undergoing chronic HD treatment.
References
Levey AS, Coresh J, Balk E, et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Ann Intern Med. 2003;139:137-47.
Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089-2100. doi:10.1111/j.1523-1755.2005.00365.x
Sabljar-Matovinović M, Kuzmanić D. Bubrezi i mokraćni sustav: Uvod. In: Vrhovac B, Francetić I, Jakšić B, Labar B, Vucelić B, editors. Interna medicina. 4th ed. Zagreb: Naklada Ljevak; 2008. p. 1075-8.
Pasternak JJ. Značaj kontinuiranog praćenja protoka arteriovenskih fistula za hemodijalizu [dissertation]. Novi Sad (RS): Univerzitet u Novom Sadu, Medicinski fakultet; 2008.
Zhang Y, Yi J, Zhang R, et al. Risk Factors for Arteriovenous Fistula Thrombus Development: A Systematic Review and Meta-Analysis. Kidney Blood Press Res. 2022;47(11):643-653. doi: 10.1159/000526768. Epub 2022 Sep 16. PMID: 36116428.
Maleta I, Vujičić B, Mesaroš- Devčić I, et al. Pristupi krvotoku za hemodijalizu. Medicina fluminensis. 2010;46(4):403-12.
Shin DH, Rhee SY, Jeon HJ, et al. An Increase in Mean Platelet Volume/Platelet Count Ratio Is Associated with Vascular Access Failure in Hemodialysis Patients. PloS ONE. 2017;12(1):e0170357. https://doi.org/10.1371/journal.pone.0170357
Rodriguez JA, Armadans L, Ferrer E, et al. The function of permanent vascular access. Nephrol Dial Transplant. 2000;15:402-8.
Smits JH, van der Linden J, Blankestijn PJ, Rabelink TJ. Coagulation and hemodialysis access thrombosis. Nephrol Dial Transplant. 2000;15(11):1755-60.
Schoorl M. Activation of platelets and coagulation during haemodialysis. Ned Tijdschr Klin Chem Labgeneesk 2016;41:17-27
McKenzie SB, edt. Clinical laboratory hematology. New Jersey: Pearson Education; 2004.
Galešić K, Sabljar-Matovinović M. Bubrezi i mokraćni sustav. Hronična bubrežna insuficijencija. In: Vrhovac B, Francetić I, Jakšić B, Labar B, Vucelić B, urednici. Interna medicina. Zagreb: Naklada Ljevak; 2003;3:1134-6.
Daugirdas JT, Bernardo AA. Hemodialysis effect on platelet count and function, and hemodialysis-associated thrombocytopenia. Kidney Int. 2012;82(2):147-57.
Akipinar I, Sayin MR, Gursoy YC, et al. Plateletcrit: A platelet marker associated with saphenous vein graft disease. Herz. 2014;39(1):142-48.
Kelley J, Sharkey LC, Christopherson PW, Rendahl A. Platelet count and plateletcrit in Cavalier King Charles Spaniels and Greyhounds using the Advia 120 and 2120. Vet Clin Pathol. 2014;43(1):43-9.
Fatih A, Vural P. Evaluation of platelet indices in acute, subacute and, chronic phases of deep venous thrombosis. CMJ. 2019;41(3):544-550 https://doi.org/10.7197/cmj.vi.610865
Schoorl M, Schoorl M, Bartels PC. Changes in platelet volume, morphology and RNA content in subjects treated with hemodialysis. Scand J Clin Lab Invest. 2008;68(4):335-42
Stolić R, Trajković G, Perić V, et al. Uticaj arterioskleroze na funkcionisanje arteriovenske fistule za hemodijalizu. Vojnosanit Pregl. 2007;64(1):13-18.
Wicaksana A, Erawan I, Kandarani Y. Association of platelet and hematocrit value with arteriovenous fistula (AVF) failure in hemodialysis patient at Bali Husada Cipta Canti, Bali, Indonesia Journal of Indonesia Vascular Access. 2022;2(1):1-3. DOI: 10.51559/jinava.v2i1.16
Chuang YC, Chen JB, Yang LC, Kuo CY. Significance of platelet activation in vascular access survival of hemodialysis patients. Nephrol Dial Transplant. 2003;18(5):947-54.
Gjorgjievski N, Dzekova-Vidimliski P, Trajcheska L, et al. Impact of preoperative arterial and venous diameter on achievement of adequate blood flow in arteriovenous fistula for hemodialysis. Ther Apher Dial. 2021;25(3):273–81.
Unčanin-Međedović S. Hronična bubrežna bolest. U: Rašić S. Klinička nefrologija. Sarajevo: Dobra knjiga. 2020;342
Stolić R, Jovanović A, Trajković G, et al. Problem kreiranja arteriovenskih fistula za hemodijalizu kod starih ljudi. Med Pregl. 2010;63(5-6):313-17.
Akkaya G, Bilen Ç. A Research for Predictive Value of Hemogram Parameters at Late Term Arteriovenous Fistula Thrombosis Formation. EJCM 2019;7(1):9-15. DOI: 10.32596/ejcm.galenos.2019.00050
Sakalli H. Factors affecting mean platelet volume in children with chronic renal failure and clinical outcomes [dissertation]. Baskent University: Faculty of Medicine; 2008
Xiong X, Li T, Yu S, Cheng B. Association Between Platelet Indices and Preoperative Deep Vein Thrombosis in Elderly Patients Undergoing Total Joint Arthroplasty: A Retrospective Study. Clin Appl Thromb Hemost. 2023;29:10760296221149699. doi:10.1177/10760296221149699
Tavil B, Bakkaloglu A, Gurgey A. Prothrombotic risk factors in patients with recurrent thrombosis of the arteriovenous fistula. Dial Transplant. 2006;35:715-30.
Elwasif SM, Megahed MO, Elmoghazy G, Derbalah SA. Unravelling the role of MPV/platelet count on vascular access function among haemodialysis Egyptian patients: A retrospective single centre study. Int. J. of Health Sci. 2022;6(S3):80607. doi:10.53730/ijhs.v6nS3.7775.
Lano G, Sallée M, Pelletier M, et al. Mean Platelet Volume Predicts Vascular Access Events in Hemodialysis Patients. J Clin Med. 2019;8(5):608. doi: 10.3390/jcm8050608.
Izzi B, Costanzo S, Gialluisi A, De Curtis A, et al. Platelet distribution width is associated with cardiovascular mortality in an adult general population. Bleeding, Thrombosis, and Vascular Biology 2023;2:83
Ju HY, Kim JK, Hur SM, et al. Could platelet volume be a promising biomarker of progression of chronic kidney disease? Platelets. 2015;26(2):143-7.
Sevuk U, Altindag R, Bahadir MV, et al. Value of platelet indices in identifying complete resolution of thrombus in deep venous thrombosis patients. Indian J Hematol Blood Transfus. 2015;31(1):71-6.
Beyan C, Kaptan K, Ifran A. Platelet count, mean platelet volume, platelet distribution withd, and plateletcrit do not correlate with optical platelet aggregation responses in healthy volunteers. J Thromb Thrombolysis. 2006;22(3):161-4.
Khandekar MM, Khurana AS, Deshmukh SD, et al. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol. 2006;59(2):146-9.
Kaller R, Arbănași EM, Mureșan AV, et al. The Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels’ Diameters in Arteriovenous Fistula Maturation Failure. Life (Basel). 2022;12(9):1447. doi:10.3390/life12091447
Churchill DN, Taylor DW, Cook RJ, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis. 1992;19(3):214-34.
Bernard D, Gouault Heilmann M, Ansquer JC, et al. Study of hemostasis factors in nephrotic syndrome. Patogenic interpretation and therapeutic deductions. Ann Med Interne (Paris). 1977;128(4):325-33.
Foley RN, Parfrey PS, Harnett JD, et al. Hypoalbuminemia cardiac morbidity and moratality in end – stage renal disease. J Am Soc Nephrol. 1996;7(5):728-36.
Kim SB, Yang WS, Park JS. Role of hypoalbuminemia in the genesis of cardiovascular disease in dialysis patients. Perit Dial Int. 1999;19 Suppl 2:S144-S149.
Valeriani E, Cangemi R, Carnevale R, et al. Hypoalbuminemia as predictor of thrombotic events in patients with community-acquired pneumonia. Int J Cardiol. 2024;404:131942. doi: 10.1016/j.ijcard.2024.131942.
Kim SB, Yang WS, Kang ES, et al. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease. Perit Dial Int. 1997;17(3):236-42.
Malindretos P, Sioulis A, Avgeriou E, et al. Angina pectoris and intensive intravenous iron treatment in hemodyalisis patients. Hippokratia. 2007;11(1):30-4.
Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate? Hematology. 2006;11(5):317-9.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 N. Klapuh-Bukvić , A. Fajkić, S. Šegalo , E. Kiseljaković , A. Bećiragić, A. Dervisevic (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
